Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls.

Yang TianDongmei WangGaoxia WeiJiesi WangHuixia ZhouHang XuQilong DaiMeihong XiuDachun ChenLi WangXiang-Yang Zhang

Published in: Psychopharmacology (2020)

There was no significant difference in the prevalence of obesity between FEDN patients and the control group. Moreover, BMI was positively associated with positive symptom severity in FEDN patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
metabolic syndrome
insulin resistance
risk factors
peritoneal dialysis
prognostic factors
weight loss
weight gain
body mass index
adipose tissue
high fat diet induced